Additional Publications: Luiz O.F. Penalva, PhD - Greehey Children's Cancer Research Institute

Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
Yi C, Li G, Ivanov DN, Wang Z, Velasco MX, Hernández G, Kaundal S, Villarreal J, Gupta YK, Qiao M, Hubert CG, Hart MJ, Penalva LOF.
RNA Biol. 2018;15(11):1420-1432. doi: 10.1080/15476286.2018.1539607.
PMID: 30362859

Increased expression of the thyroid hormone nuclear receptor TRα1 characterizes intestinal tumors with high Wnt activity.
Uchuya-Castillo J, Aznar N, Frau C, Martinez P, Le Nevé C, Marisa L, Penalva LOF, Laurent-Puig P, Puisieux A, Scoazec JY, Samarut J, Ansieau S, Plateroti M.
Oncotarget. 2018 Jul 24;9(57):30979-30996. doi: 10.18632/oncotarget.25741. eCollection 2018 Jul 24.
PMID: 30123421

Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity.
Correa BRS, Hu J, Penalva LOF, Schlegel R, Rimm DL, Galante PAF, Agarwal S.
Sci Rep. 2018 Mar 6;8(1):4097. doi: 10.1038/s41598-018-22427-1.
PMID: 29511269

The 3′ end of the story: deciphering combinatorial interactions that control mRNA fate.
Sanford JR, Penalva LOF.
Genome Biol. 2017 Nov 29;18(1):227. doi: 10.1186/s13059-017-1360-6.
PMID: 29187223

MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.
Cirilo PDR, de Sousa Andrade LN, Corrêa BRS, Qiao M, Furuya TK, Chammas R, Penalva LOF.
BMC Cancer. 2017 Nov 10;17(1):750. doi: 10.1186/s12885-017-3721-7.
PMID: 29126391

From mechanisms to therapy: RNA processing’s impact on human genetics.
Penalva LO, Sanford JR.
Hum Genet. 2017 Sep;136(9):1013-1014. doi: 10.1007/s00439-017-1841-4.
PMID: 28866814

RNA processing as an alternative route to attack glioblastoma.
Marcelino Meliso F, Hubert CG, Favoretto Galante PA, Penalva LO.
Hum Genet. 2017 Sep;136(9):1129-1141. doi: 10.1007/s00439-017-1819-2
PMID:28608251

Riborex: fast and flexible identification of differential translation from Ribo-seq data.
Li W, Wang W, Uren PJ, Penalva LOF, Smith AD.
Bioinformatics. 2017 Jun 1;33(11):1735-1737. doi: 10.1093/bioinformatics/btx047.
PMID: 28158331

Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit.
de Araujo PR, Gorthi A, da Silva AE, Tonapi SS, Vo DT, Burns SC, Qiao M, Uren PJ, Yuan ZM, Bishop AJ, Penalva LO.
Am J Pathol. 2016 Sep;186(9):2271-8. doi: 10.1016/j.ajpath.2016.05.020.
PMID: 27470713

Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
Correa BR, de Araujo PR, Qiao M, Burns SC, Chen C, Schlegel R, Agarwal S, Galante PA, Penalva LO.
Genome Biol. 2016 Jun 10;17(1):125. doi: 10.1186/s13059-016-0990-4.
PMID: 27287018

IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC.
Ennajdaoui H, Howard JM, Sterne-Weiler T, Jahanbani F, Coyne DJ, Uren PJ, Dargyte M, Katzman S, Draper JM, Wallace A, Cazarez O, Burns SC, Qiao M, Hinck L, Smith AD, Toloue MM, Blencowe BJ, Penalva LO, Sanford JR.
Cell Rep. 2016 May 31;15(9):1876-83. doi: 10.1016/j.celrep.2016.04.083.
PMID: 27210763

High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.
Uren PJ, Bahrami-Samani E, de Araujo PR, Vogel C, Qiao M, Burns SC, Smith AD, Penalva LO.
RNA Biol. 2016;13(4):400-11. doi: 10.1080/15476286.2015.1138030.
PMID:26760575

miR-124, -128, and -137 Orchestrate Neural Differentiation by Acting on Overlapping Gene Sets Containing a Highly Connected Transcription Factor Network.
Santos MC, Tegge AN, Correa BR, Mahesula S, Kohnke LQ, Qiao M, Ferreira MA, Kokovay E, Penalva LO.
Stem Cells. 2016 Jan;34(1):220-32. doi: 10.1002/stem.2204.
PMID: 26369286